Renol Polychem Ltd.
•₹ 81.750.62%
2026-08-21
PROS
- Working capital cycle has improved - days down from 473 to 73
- Company comfortably covers its interest (12.1x coverage)
- Company converts assets efficiently - asset turnover of 3.2x
CONS
- Operating cash flow has been negative in recent years
- Total debt has risen sharply - up 169.7% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SOLARINDS | 19650.00 | 89.29 | 177812.96 | 0.06 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| 2. | PIDILITIND | 1662.05 | 63.86 | 169161.84 | 1.29 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| 3. | SRF | 2570.50 | 35.25 | 76196.00 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| 4. | FLUOROCHEM | 4678.85 | 83.57 | 51397.17 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 10.02 | 26.83 |
| 5. | NAVINFLUOR | 8250.30 | 53.60 | 42324.05 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| 6. | GODREJIND | 1226.50 | 35.14 | 41314.78 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| 7. | DEEPAKNTR | 1749.95 | 30.47 | 23868.10 | 0.43 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| 8. | AETHER | 1634.55 | 92.24 | 21695.03 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| 9. | ATUL | 6520.15 | 24.13 | 19196.47 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| 10. | AARTIIND | 521.50 | 35.62 | 18916.20 | 0.19 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.39 | 16.00 |
| 11. | DEEPAKFERT | 1458.05 | 18.77 | 18468.08 | 0.69 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| 12. | RNPL | 81.25 | 11.89 | 98.19 | 0.00 | — | — | — | — | 46.02 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 6 | 62 | |
| 4 | 55 | |
| Operating Profit | 2 | 7 |
| OPM % | 36 | 12 |
| Other Income | 0 | 0 |
| Interest | 0 | 1 |
| Depreciation | 0 | 0 |
| 2 | 7 | |
| Tax % | 30 | 25 |
| Net Profit | 2 | 5 |
| EPS | 3 | 9 |
| Dividend Payout % | 0 | 0 |
| Minority Interest | 0 | 0 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 3 | 9 |
| Minority Interest | 0 | 0 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 3 | 9 |
Mar 2024
- 6
- 4
- Operating Profit
- 2
- OPM %
- 36
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 30
- Net Profit
- 2
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 62
- 55
- Operating Profit
- 7
- OPM %
- 12
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 7
- Tax %
- 25
- Net Profit
- 5
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 9%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- Last Year:
- 45%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| LIABILITIES | - | - |
| Equity Capital | 5 | 5 |
| 3 | 8 | |
| 2 | 7 | |
| Trade Payables | 2 | 1 |
| 2 | 2 | |
| Total Liabilities | 15 | 23 |
| ASSETS | - | - |
| 0 | 0 | |
| 7 | 9 | |
| 6 | 9 | |
| Cash & Bank | 1 | 3 |
| 1 | 2 | |
| Total Assets | 15 | 23 |
| Total Debt | 3 | 7 |
| Net Working Capital | 8 | 12 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 15.83 | 24.28 |
| Face Value | 10.00 | 10.00 |
| Total Debt | 3 | 7 |
| Net Working Capital | 8 | 12 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 15.83 | 24.28 |
| Face Value | 10.00 | 10.00 |
Mar 2024
- Equity Capital
- 5
- 3
- 2
- Trade Payables
- 2
- 2
- Total Liabilities
- 15
- 0
- 7
- 6
- Cash & Bank
- 1
- 1
- Total Assets
- 15
- Total Debt
- 3
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 15.83
- Face Value
- 10.00
- Total Debt
- 3
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 15.83
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 5
- 8
- 7
- Trade Payables
- 1
- 2
- Total Liabilities
- 23
- 0
- 9
- 9
- Cash & Bank
- 3
- 2
- Total Assets
- 23
- Total Debt
- 7
- Net Working Capital
- 12
- Contingent Liabilities
- 0
- Book Value per Share
- 24.28
- Face Value
- 10.00
- Total Debt
- 7
- Net Working Capital
- 12
- Contingent Liabilities
- 0
- Book Value per Share
- 24.28
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 1 | -1 | |
| Cash from Investing | 0 | -0 |
| Cash from Financing | -0 | 4 |
| 1 | 2 | |
| Free Cash Flow | 1 | -1 |
| OCF / Net Profit | 0.78 | -0.25 |
| Cumulative 5-Year FCF | 0 | 0 |
| OCF / Net Profit | 0.78 | -0.25 |
| Cumulative 5-Year FCF | 0 | 0 |
Mar 2024
- 1
- Cash from Investing
- 0
- Cash from Financing
- -0
- 1
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 0
Mar 2025
- -1
- Cash from Investing
- -0
- Cash from Financing
- 4
- 2
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.25
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.25
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| PER SHARE | - | - |
| EPS (₹) | 2.79 | 9.10 |
| Book Value (₹) | 15.83 | 24.28 |
| Dividend per Share (₹) | 0.00 | 0.00 |
| Cash EPS (₹) | 2.83 | 9.36 |
| PROFITABILITY | - | - |
| Operating Margin % | 34.53% | 11.46% |
| Net Margin % | 23.78% | 8.02% |
| ROE % | 17.65% | 45.37% |
| ROCE % | 20.23% | 46.02% |
| 9.93% | 25.75% | |
| EFFICIENCY | - | - |
| Debtor Days | 351 | 44 |
| Inventory Days | 392 | 47 |
| Payable Days | 229 | 12 |
| 514 | 80 | |
| FINANCIAL HEALTH | - | - |
| Debt to Equity (x) | 0.30x | 0.52x |
| Interest Coverage (x) | 22.38x | 12.14x |
| 2.28x | 2.25x | |
| GROWTH | - | - |
| Revenue Growth % | 0.00% | 865.98% |
| Operating Profit Growth % | 0.00% | 221.93% |
| Net Profit Growth % | 0.00% | 225.76% |
| 0.00% | 225.76% | |
| VALUATION | - | - |
| P/E (x) | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% |
| 3.07x | 1.28x |
Mar 2024
- EPS (₹)
- 2.79
- Book Value (₹)
- 15.83
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.83
- Operating Margin %
- 34.53%
- Net Margin %
- 23.78%
- ROE %
- 17.65%
- ROCE %
- 20.23%
- 9.93%
- Debtor Days
- 351
- Inventory Days
- 392
- Payable Days
- 229
- 514
- Debt to Equity (x)
- 0.30x
- Interest Coverage (x)
- 22.38x
- 2.28x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.07x
Mar 2025
- EPS (₹)
- 9.10
- Book Value (₹)
- 24.28
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 9.36
- Operating Margin %
- 11.46%
- Net Margin %
- 8.02%
- ROE %
- 45.37%
- ROCE %
- 46.02%
- 25.75%
- Debtor Days
- 44
- Inventory Days
- 47
- Payable Days
- 12
- 80
- Debt to Equity (x)
- 0.52x
- Interest Coverage (x)
- 12.14x
- 2.25x
- Revenue Growth %
- 865.98%
- Operating Profit Growth %
- 221.93%
- Net Profit Growth %
- 225.76%
- 225.76%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.28x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.